Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/25/16 → 11/20/19 |
Funding
- PPD Investigator Services LLC: $35,306.92
Vascular Biogenics: A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-Center Study of VB-111 Combined with Bevacizumab vs. Bevacizumab Monotherapy in Patients with Recurrent Glioblastoma
- Kowalska, Agnieszka (PI)
- Chesler, David (CoPI)
- Davis, Raphael (CoPI)
- Gutman, Frederick (CoPI)
Project: Research